Annual Drug Patent Expirations for DURYSTA
Durysta is a drug marketed by Allergan Inc and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug.
This drug has one hundred and forty-seven patent family members in thirty-one countries.
The generic ingredient in DURYSTA is bimatoprost. One supplier is listed for this compound. Additional details are available on the bimatoprost profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
